These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11696365)

  • 41. Pituitary adenylate cyclase-activating polypeptide receptors mediating insulin secretion in rodent pancreatic islets are coupled to adenylate cyclase but not to PLC.
    Jamen F; Puech R; Bockaert J; Brabet P; Bertrand G
    Endocrinology; 2002 Apr; 143(4):1253-9. PubMed ID: 11897681
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Substance P, neurokinin A, vasoactive intestinal polypeptide and gastrin releasing peptide in the intestine and pancreas of spontaneously obese-diabetic mice.
    Bailey CJ; Flatt PR; Deacon CF; Shaw C; Conlon JM
    Regul Pept; 1986 Dec; 16(3-4):339-48. PubMed ID: 2436255
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CD26/dipeptidyl peptidase IV and its role in cancer.
    Pro B; Dang NH
    Histol Histopathol; 2004 Oct; 19(4):1345-51. PubMed ID: 15375776
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pituitary adenylate cyclase activating polypeptide and vasoactive intestinal peptide increase cytosolic free calcium concentration in cultured rat hippocampal neurons.
    Tatsuno I; Yada T; Vigh S; Hidaka H; Arimura A
    Endocrinology; 1992 Jul; 131(1):73-81. PubMed ID: 1319331
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of pituitary adenylate cyclase-activating polypeptide in the pancreatic endocrine system.
    Ahrén B
    Ann N Y Acad Sci; 2008 Nov; 1144():28-35. PubMed ID: 19076360
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pituitary adenylate cyclase-activating peptide (PACAP): assessment of dipeptidyl peptidase IV degradation, insulin-releasing activity and antidiabetic potential.
    Green BD; Irwin N; Flatt PR
    Peptides; 2006 Jun; 27(6):1349-58. PubMed ID: 16406202
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of total or partial uterus extirpation on sympathetic uterus-projecting neurons in porcine inferior mesenteric ganglion. B. Changes in expression of neuropeptide Y, galanin, vasoactive intestinal polypeptide, pituitary adenylate-cyclase activating peptide, somatostatin and substance P.
    Wasowicz K
    Pol J Vet Sci; 2003; 6(2):147-60. PubMed ID: 12817785
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dipeptidyl peptidase inhibitors as new drugs for the treatment of type 2 diabetes.
    Mest HJ; Mentlein R
    Diabetologia; 2005 Apr; 48(4):616-20. PubMed ID: 15770466
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Functional characterization and mRNA expression of pituitary adenylate cyclase activating polypeptide (PACAP) type I receptors in rat peritoneal macrophages.
    Pozo D; Delgado M; Martinez C; Gomariz RP; Guerrero JM; Calvo JR
    Biochim Biophys Acta; 1997 Dec; 1359(3):250-62. PubMed ID: 9434131
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PACAP/VIP receptors in pancreatic beta-cells: their roles in insulin secretion.
    Inagaki N; Kuromi H; Seino S
    Ann N Y Acad Sci; 1996 Dec; 805():44-51; discussion 52-3. PubMed ID: 8993392
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dipeptidyl peptidase IV in the hypothalamus and hippocampus of monosodium glutamate obese and food-deprived rats.
    Alponti RF; Frezzatti R; Barone JM; Alegre Vde S; Silveira PF
    Metabolism; 2011 Feb; 60(2):234-42. PubMed ID: 20153005
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hypothalamic binding sites for pituitary adenylate cyclase activating polypeptide: characterization and molecular identification.
    Gottschall PE; Tatsuno I; Arimura A
    FASEB J; 1991 Feb; 5(2):194-9. PubMed ID: 1848519
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP-receptor type 1 expression in rat and human placenta.
    Scaldaferri ML; Modesti A; Palumbo C; Ulisse S; Fabbri A; Piccione E; Frajese G; Moretti C
    Endocrinology; 2000 Mar; 141(3):1158-67. PubMed ID: 10698193
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fluorogenic substrate [Ala-Pro]2-cresyl violet but not Ala-Pro-rhodamine 110 is cleaved specifically by DPPIV activity: a study in living Jurkat cells and CD26/DPPIV-transfected Jurkat cells.
    Boonacker E; Elferink S; Bardai A; Fleischer B; Van Noorden CJ
    J Histochem Cytochem; 2003 Jul; 51(7):959-68. PubMed ID: 12810846
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuropeptide regulation of interleukin-6 production from the pituitary: stimulation by pituitary adenylate cyclase activating polypeptide and calcitonin gene-related peptide.
    Tatsuno I; Somogyvari-Vigh A; Mizuno K; Gottschall PE; Hidaka H; Arimura A
    Endocrinology; 1991 Oct; 129(4):1797-804. PubMed ID: 1655384
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) activate protein kinase C in chick cerebral cortex.
    Nowak JZ; Dejda A; Zawilska JB
    Pol J Pharmacol; 2001; 53(6):695-9. PubMed ID: 11985349
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family.
    Lambeir AM; Proost P; Durinx C; Bal G; Senten K; Augustyns K; Scharpé S; Van Damme J; De Meester I
    J Biol Chem; 2001 Aug; 276(32):29839-45. PubMed ID: 11390394
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cloning and functional characterization of a third pituitary adenylate cyclase-activating polypeptide receptor subtype expressed in insulin-secreting cells.
    Inagaki N; Yoshida H; Mizuta M; Mizuno N; Fujii Y; Gonoi T; Miyazaki J; Seino S
    Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2679-83. PubMed ID: 8146174
    [TBL] [Abstract][Full Text] [Related]  

  • 59. DPPIV/CD26: a tumor suppressor or a marker of malignancy?
    Beckenkamp A; Davies S; Willig JB; Buffon A
    Tumour Biol; 2016 Jun; 37(6):7059-73. PubMed ID: 26943912
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dipeptidyl-peptidase-IV by cleaving neuropeptide Y induces lipid accumulation and PPAR-γ expression.
    Rosmaninho-Salgado J; Marques AP; Estrada M; Santana M; Cortez V; Grouzmann E; Cavadas C
    Peptides; 2012 Sep; 37(1):49-54. PubMed ID: 22819773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.